市場調查報告書

抗感染疾病藥的全球市場:機會及策略

Anti-Infective Drugs Global Market Opportunities And Strategies To 2022

出版商 The Business Research Company 商品編碼 907277
出版日期 內容資訊 英文 280 Pages
商品交期: 2-3個工作天內
價格
Back to Top
抗感染疾病藥的全球市場:機會及策略 Anti-Infective Drugs Global Market Opportunities And Strategies To 2022
出版日期: 2019年08月13日內容資訊: 英文 280 Pages
簡介

本報告提供全球抗感染疾病藥市場相關調查分析,市場概要,產品分析,市場趨勢,市場機會等相關考察,各地區市場分析,主要企業的簡介等相關資訊整體性分析、彙整。

第1章 抗感染疾病藥市場摘要整理

第2章 目錄

第3章 圖表一覽

第4章 表格一覽

第5章 報告內容架構

第6章 簡介

第7章 抗感染疾病藥市場特徵

第8章 抗感染疾病藥市場:產品分析

第9章 抗感染疾病藥市場:供應鏈分析

第10章 抗感染疾病藥市場:客戶資訊

第11章 抗感染疾病藥市場:趨勢與策略

第12章 抗感染疾病藥市場:機會評估:PESTEL分析

第13章 抗感染疾病藥市場:規模與成長

第14章 抗感染疾病藥市場:地區分析

第15章 全球抗感染疾病藥市場:市場區隔

第16章 抗感染疾病藥市場標準

第17章 亞太地區的抗感染疾病藥市場

第18章 西歐的抗感染疾病藥市場

第19章 東歐的抗感染疾病藥市場

第20章 北美的抗感染疾病藥市場

第21章 南美的抗感染疾病藥市場

第22章 中東的抗感染疾病藥市場

第23章 非洲的抗感染疾病藥市場

第24章 全球抗感染疾病藥市場競爭情形

第25章 抗感染疾病藥市場主要M&A

第26章 市場背景:醫藥品市場

第27章 全球抗感染疾病藥市場:機會及策略

第28章 抗感染疾病藥市場:結論與提案

第29章 附錄

目錄

Anti-Infective Drugs Global Market Opportunities And Strategies To 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the anti-infective drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global anti-infective drugs market report to 2022 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Market Characteristics - The market characteristics section of the report defines and explains the anti-infective drugs market. This chapter identifies the different products covered in the report and basic definitions.
  • Supply Chain - The supply chain section of the report defines and explains the key players in the anti-infective drugs industry supply chain.
  • Trends And Strategies - This chapter describes the major trends shaping the global anti-infective drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • PESTEL Analysis - This chapter describes the market opportunity assessment through PESTEL analysis.
  • Global Market Size And Growth - This section contains the global historic (2014-2018) and forecast (2018-2022) market value, and drivers and restraints that support and control the growth of the market in the historic and forecast period.
  • Regional Analysis - This section contains the historic (2014-2018) and forecast (2018-2022) market value and growth, and market share comparison by region.
  • Market Segmentation - This section contains the market values (2014-2022) and analysis for different market segments.
  • Global Macro Comparison The global anti-infective drugs market comparison with macro-economic factors gives the anti-infective drugs market size, percentage of GDP, and average anti-infective drugs market expenditure.
  • Regional Market Size and Growth - This section contains the region's market size (2018), historic (2014-2018) and forecast (2018-2022) market value, and growth and market share comparison of major countries within the region. This section also gives information on industry metrics which affect or influence the anti-infective drugs market. Industry metrics covered in this section include per capita average anti-infective drugs market expenditure. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa) and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global anti-infective drugs market, estimated market shares and company profiles of the leading players.
  • Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Background - This section describes the pharmaceutical drugs market of which the anti-infective drugs market is a segment. This chapter includes the global pharmaceutical drugs market 2014-18 and 2018-22 values, and regional analysis for the pharmaceutical drugs market.
  • Conclusions & Recommendations - This section includes conclusions and recommendations are based on findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Appendix - This section includes details on the market data sources, abbreviations and currencies codes used in this report.

Markets Covered:

  • By Product Type: Antibiotics, Antivirals, Antifungals and Others
  • Antibiotics is further segmented into B-Lactams, Quinolones, Macrolides, Aminoglycosides and Others
  • Antivirals is further segmented into Hepatitis Therapeutics, Herpes Therapeutics, HIV AIDS Therapeutics and Influenza Therapeutics
  • Antifungals is further segmented into Azoles and Others
  • Companies Mentioned: Gilead Sciences, GlaxoSmithKline, Merck & Co, Teva Pharmaceutical Industries Ltd., Johnson & Johnson
  • Countries: China, Japan, India, Australia, Indonesia, Malaysia, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Canada, Mexico, USA, Argentina, Brazil, Chile, Colombia, Peru, Venezuela,UK, Belgium, Denmark, Finland, France, Ireland, Italy, Netherlands, Norway, Portugal, Sweden , Switzerland, Germany, France, Spain, Czech Republic, Poland, Romania, Russia, Saudi Arabia, Israel, Turkey, UAE, Egypt, Nigeria, South Africa.
  • Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time series: Five years historic and forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Anti-Infective Drugs Market Executive Summary

2. Table Of Contents

3. List Of Figures

4. List Of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography
  • 6.2. Segmentation By Product Type

7. Anti-Infective Drugs Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Product Type
    • 7.2.1. Antibiotics
    • 7.2.2. Antivirals
    • 7.2.3. Antifungals
    • 7.2.4. Others (Anthelminthic, Antiprotozoal)

8. Anti-Infective Drugs Market Product Analysis

9. Anti-Infective Drugs Market Supply Chain Analysis

  • 9.1. Raw Material Suppliers
  • 9.2. Contract Research Organization (CRO)
  • 9.3. Anti-Infective Drugs Manufacturer
  • 9.4. Contract Manufacturing Organization (CMO)
  • 9.5. Wholesalers/Distributors
  • 9.6. Retailers (Pharmacies) And Hospitals
  • 9.7. End-Users

10. Anti-Infective Drugs Market Customer Information

  • 10.1. Willingness Towards Alternative Distribution And Dispensing Of Antiviral Drugs
  • 10.2. Extensive Use Of Antibiotics In Low Income Countries
  • 10.3. Anti-Parasitic Drugs May Improve Long Term Clinical Outcomes
  • 10.4. Antifungal Drugs Are Widely Used By The Pediatric Population
  • 10.5. Frequency Of Anti-Malarial Drug Use
  • 10.6. High Proportion of Americans Consume Prescription Drugs
  • 10.7. Consumers Find Generics As Good As Prescription Drugs

11. Anti-Infective Drugs Market Trends And Opportunities

  • 11.1. Strategic Collaborations And Agreements
  • 11.2. Demand For New Medicines For Drug-Resistant Infections
  • 11.3. Global Research Initiatives And Funding
  • 11.4. 3D Printing Technology
  • 11.5. Termination Of R&D Pipelines Of Anti-Infective Drugs
  • 11.6. Diversification Of Portfolios And Enhanced Focus On The Chronic Segment
  • 11.7. Increasing Number Of Pipeline Studies And Drug Development

12. Anti-Infective Drugs Market Opportunity Assessment, PESTEL Analysis

  • 12.1. Political
    • 12.1.1. Government Initiatives
    • 12.1.2. Political Uncertainties
  • 12.2. Economic
    • 12.2.1. Emerging Economies
    • 12.2.2. Inflated Drug Prices
    • 12.2.3. Rising Disposable Incomes
  • 12.3. Social
    • 12.3.1. Aging Global Population
    • 12.3.2. Health Consciousness And Awareness
    • 12.3.3. Shortages Of Human Resources
  • 12.4. Technological
    • 12.4.1. Internet Connectivity Rising Awareness
  • 12.5. Environmental
  • 12.6. Environmental Pollution
  • 12.7. Natural Disasters
  • 12.8. Legal
    • 12.8.1. Stringent Regulations
    • 12.8.2. Lengthy Drug Approval Processes

13. Global Anti-Infective Drugs Market Size And Growth

  • 13.1. Market Size
  • 13.2. Historic Market Growth, Value ($ Billion)
    • 13.2.1. Drivers Of The Market 2014-18
      • 13.2.1.1. Rise In Incidence Rates Of Infectious Diseases
      • 13.2.1.2. Population Aging
      • 13.2.1.3. Growth Of Emerging Markets
    • 13.2.2. Restraints On The Market 2014-18
      • 13.2.2.1. Patent Expiration Of Drugs
      • 13.2.2.2. Low Returns On Investments
  • 13.3. Forecast Market Growth, Value ($ Billion)
    • 13.3.1. Drivers Of The Market 2018-22
      • 13.3.1.1. Developments In Drug Discovery Procedures
      • 13.3.1.2. Increase In The Sepsis Prevalence
      • 13.3.1.3. Economic Growth
    • 13.3.2. Restraints On The Market 2018-22
      • 13.3.2.1. Increasing Antimicrobial Resistance
      • 13.3.2.2. Supply Shortages Of Anti-Infective Drugs
      • 13.3.2.3. Reductions In Free Trade

14. Anti-Infective Drugs Market Regional Analysis

  • 14.1. Global Anti-Infective Drugs Market, 2018, By Region, Value ($ Billion)
  • 14.2. Global Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 14.3. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region

15. Global Anti-Infective Drugs Market Segmentation

  • 15.1. Global Anti-Infective Drugs Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)
  • 15.2. Global Antibiotics Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)
  • 15.3. Global Antivirals Market, Segmentation By Therapeutic Type, 2014 - 2022, Value ($ Billion)
  • 15.4. Global Antifungals Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)

16. Global Anti-Infective Drugs Market Metrics

  • 16.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global
  • 16.2. Per Capita Average Anti-Infective Drugs Expenditure, Global

17. Asia-Pacific Anti-Infective Drugs Market

  • 17.1. Asia-Pacific Anti-infective Drugs Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Market Information
    • 17.1.3. Background Information
    • 17.1.4. Government Initiatives
    • 17.1.5. Regulations
    • 17.1.6. Regulatory Bodies
    • 17.1.7. Tax Levied
    • 17.1.8. Associations
    • 17.1.9. Corporate Tax Structure
    • 17.1.10. Investments
    • 17.1.11. Major Companies
  • 17.2. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
  • 17.3. Asia-Pacific Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.4. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.5. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.6. Asia-Pacific Anti-Infective Drugs Market Metrics
  • 17.7. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Asia-Pacific Countries
  • 17.8. Asia-Pacific Anti-Infective Drugs Market: Country Analysis
    • 17.8.1. Australia Anti-Infective Drugs Market
    • 17.8.2. Australia Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 17.8.3. China Anti-Infective Drugs Market
      • 17.8.3.1. China Anti-Infective Drugs Market Overview
      • 17.8.3.1.1. Country Information
      • 17.8.3.1.2. Market Information
      • 17.8.3.1.3. Background Information
      • 17.8.3.1.4. Government Initiatives
      • 17.8.3.1.5. Regulations
      • 17.8.3.1.6. Regulatory Bodies
      • 17.8.3.1.7. Tax Levied
      • 17.8.3.1.8. Associations
      • 17.8.3.1.9. Corporate Tax Structure
      • 17.8.3.1.10. Investments
      • 17.8.3.1.11. Major Companies
      • 17.8.3.2. China Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 17.8.4. Hong Kong Anti-Infective Drugs Market
      • 17.8.4.1. Hong Kong Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.8.5. India Anti-Infective Drugs Market
    • 17.8.6. India Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 17.8.7. Indonesia Anti-Infective Drugs Market
      • 17.8.7.1. Indonesia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.8.8. Japan Anti-Infective Drugs Market
      • 17.8.8.1. Japan Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 17.8.9. Malaysia Anti-Infective Drugs Market
    • 17.8.10. Malaysia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.8.11. New Zealand Anti-Infective Drugs Market
    • 17.8.12. New Zealand Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.8.13. Philippines Anti-Infective Drugs Market
      • 17.8.13.1. Philippines Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.8.14. Singapore Anti-Infective Drugs Market
      • 17.8.14.1. Singapore Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.8.15. South Korea Anti-Infective Drugs Market
    • 17.8.16. South Korea Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.8.17. Thailand Anti-Infective Drugs Market
    • 17.8.18. Thailand Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.8.19. Vietnam Anti-Infective Drugs Market
      • 17.8.19.1. Vietnam Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)

18. Western Europe Anti-Infective Drugs Market

  • 18.1. Western Europe Anti-infective Drugs Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. Background Information
    • 18.1.4. Government Initiatives
    • 18.1.5. Regulations
    • 18.1.6. Regulatory Bodies
    • 18.1.7. Tax Levied
    • 18.1.8. Associations
    • 18.1.9. Corporate Tax Structure
    • 18.1.10. Investments
    • 18.1.11. Major Companies
  • 18.2. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
  • 18.3. Western Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.4. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.5. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.6. Western Europe Anti-Infective Drugs Market Metrics
    • 18.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Western Europe Countries
  • 18.7. Western Europe Anti-Infective Drugs Market: Country Analysis
    • 18.7.1. Austria Anti-Infective Drugs Market
      • 18.7.1.1. Austria Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Belgium Anti-Infective Drugs Market
      • 18.7.2.1. Belgium Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. Denmark Anti-Infective Drugs Market
      • 18.7.3.1. Denmark Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.4. Finland Anti-Infective Drugs Market
      • 18.7.4.1. Finland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.5. France Anti-Infective Drugs Market
      • 18.7.5.1. France Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 18.7.6. Germany Anti-Infective Drugs Market
      • 18.7.6.1. Germany Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 18.7.7. Ireland Anti-Infective Drugs Market
      • 18.7.7.1. Ireland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.8. Italy Anti-Infective Drugs Market
      • 18.7.8.1. Italy Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 18.7.9. Netherlands Anti-Infective Drugs Market
      • 18.7.9.1. Netherlands Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.10. Norway Anti-Infective Drugs Market
      • 18.7.10.1. Norway Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.11. Portugal Anti-Infective Drugs Market
    • 18.7.12. Portugal Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.13. Spain Anti-Infective Drugs Market
      • 18.7.13.1. Spain Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 18.7.14. Sweden Anti-Infective Drugs Market
      • 18.7.14.1. Sweden Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.15. Switzerland Anti-Infective Drugs Market
      • 18.7.15.1. Switzerland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.16. UK Anti-Infective Drugs Market
      • 18.7.16.1. UK Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)

19. Eastern Europe Anti-Infective Drugs Market

  • 19.1. Eastern Europe Anti-infective Drugs Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Background Information
    • 19.1.4. Government Initiatives
    • 19.1.5. Regulations
    • 19.1.6. Regulatory Bodies
    • 19.1.7. Tax Levied
    • 19.1.8. Associations
    • 19.1.9. Corporate Tax Structure
    • 19.1.10. Investments
    • 19.1.11. Major Companies
  • 19.2. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
  • 19.3. Eastern Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • 19.4. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 19.5. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 19.6. Eastern Europe Anti-Infective Drugs Market Metrics
    • 19.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Eastern Europe Countries
  • 19.7. Eastern Europe Anti-Infective Drugs Market: Country Analysis
    • 19.7.1. Czech Republic Anti-Infective Drugs Market
      • 19.7.1.1. Czech Republic Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 19.7.2. Poland Anti-Infective Drugs Market
      • 19.7.2.1. Poland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 19.7.3. Romania Anti-Infective Drugs Market
      • 19.7.3.1. Romania Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 19.7.4. Russia Anti-Infective Drugs Market
      • 19.7.4.1. Russia Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)

20. North America Anti-Infective Drugs Market

  • 20.1. North America Anti-infective Drugs Market Overview
    • 20.1.1. Region Information
    • 20.1.2. Market Information
    • 20.1.3. Background Information
    • 20.1.4. Government Initiatives
    • 20.1.5. Regulatory Bodies
    • 20.1.6. Tax Levied
    • 20.1.7. Associations
    • 20.1.8. Corporate Tax Structure
    • 20.1.9. Investments
    • 20.1.10. Major Companies
  • 20.2. North America Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
  • 20.3. North America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • 20.4. North America Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 20.5. Growth has slowed in most countries of the North America anti-infective drugs market, accelerating in Mexico.
  • 20.6. North America Anti-Infective Drugs Market, 2018 - 2022, Growth And Market Share Comparison, By Country
  • 20.7. North America Anti-Infective Drugs Market Metrics
    • 20.7.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, North America Countries
  • 20.8. North America Anti-Infective Drugs Market: Country Analysis
    • 20.8.1. USA Anti-Infective Drugs Market
      • 20.8.1.1. USA Anti-infective Drugs Market Overview
      • 20.8.1.1.1. Country Information
      • 20.8.1.1.2. Market Information
      • 20.8.1.1.3. Background Information
      • 20.8.1.1.4. Government Initiatives
      • 20.8.1.1.5. Regulatory Bodies
      • 20.8.1.1.6. Tax Levied
      • 20.8.1.1.7. Associations
      • 20.8.1.1.8. Corporate Tax Structure
      • 20.8.1.1.9. Investments
      • 20.8.1.1.10. Major Companies
      • 20.8.1.2. USA Anti-Infective Drugs Market
      • 20.8.1.3. USA Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 20.8.2. Canada Anti-Infective Drugs Market
      • 20.8.2.1. Canada Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 20.8.3. Mexico Anti-Infective Drugs Market
    • 20.8.4. Mexico Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)

21. South America Anti-Infective Drugs Market

  • 21.1. South America Anti-infective Drugs Market Overview
    • 21.1.1. Region Information
    • 21.1.2. Market Information
    • 21.1.3. Background Information
    • 21.1.4. Government Initiatives
    • 21.1.5. Regulations
    • 21.1.6. Regulatory Bodies
    • 21.1.7. Tax Levied
    • 21.1.8. Associations
    • 21.1.9. Corporate Tax Structure
    • 21.1.10. Investments
    • 21.1.11. Major Companies
  • 21.2. South America Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
  • 21.3. South America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • 21.4. South America Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 21.5. Growth has slowed in most counties of the South American anti-infective drugs market, accelerating in Colombia and Venezuela.
  • 21.6. South America Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 21.7. South America Anti-Infective Drugs Market Metrics
    • 21.7.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, South America Countries
  • 21.8. South America Anti-Infective Drugs Market: Country Analysis
    • 21.8.1. Argentina Anti-Infective Drugs Market
      • 21.8.1.1. Argentina Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 21.8.2. Brazil Anti-Infective Drugs Market
      • 21.8.2.1. Brazil Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 21.8.3. Chile Anti-Infective Drugs Market
      • 21.8.3.1. Chile Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 21.8.4. Colombia Anti-Infective Drugs Market
      • 21.8.4.1. Colombia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 21.8.5. Peru Anti-Infective Drugs Market
      • 21.8.5.1. Peru Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 21.8.6. Venezuela Anti-Infective Drugs Market
      • 21.8.6.1. Venezuela Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)

22. Middle East Anti-Infective Drugs Market

  • 22.1. Middle East Anti-infective Drugs Market Overview
    • 22.1.1. Region Information
    • 22.1.2. Market Information
    • 22.1.3. Background Information
    • 22.1.4. Government Initiatives
    • 22.1.5. Regulatory Bodies
    • 22.1.6. Tax Levied
    • 22.1.7. Corporate Tax Structure
    • 22.1.8. Investments
    • 22.1.9. Major Companies
  • 22.2. Middle East Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
  • 22.3. Middle East Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • 22.4. Middle East Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 22.5. Middle East Anti-Infective Drugs Market, 2018 - 2022, Growth And Market Share Comparison, By Country
  • 22.6. Middle East Anti-Infective Drugs Market Metrics
    • 22.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Middle East Countries
  • 22.7. Middle East Anti-Infective Drugs Market: Country Analysis
    • 22.7.1. Israel Anti-Infective Drugs Market
      • 22.7.1.1. Israel Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 22.7.2. Saudi Arabia Anti-Infective Drugs Market
      • 22.7.2.1. Saudi Arabia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 22.7.3. Turkey Anti-Infective Drugs Market
      • 22.7.3.1. Turkey Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 22.7.4. UAE Anti-Infective Drugs Market
    • 22.7.5. UAE Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)

23. Africa Anti-Infective Drugs Market

  • 23.1. Africa Anti-infective Drugs Market Overview
    • 23.1.1. Region Information
    • 23.1.2. Market Information
    • 23.1.3. Background Information
    • 23.1.4. Government Initiatives
    • 23.1.5. Regulations
    • 23.1.6. Regulatory Bodies
    • 23.1.7. Tax Levied
    • 23.1.8. Corporate Tax Structure
    • 23.1.9. Investments
    • 23.1.10. Major Companies
  • 23.2. Africa Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
  • 23.3. Africa Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • 23.4. Africa Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 23.5. Africa Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 23.6. Africa Anti-Infective Drugs Market Metrics
    • 23.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Africa Countries
  • 23.7. Africa Anti-Infective Drugs Market: Country Analysis
    • 23.7.1. Egypt Anti-Infective Drugs Market
      • 23.7.1.1. Egypt Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 23.7.2. Nigeria Anti-Infective Drugs Market
      • 23.7.2.1. Nigeria Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
    • 23.7.3. South Africa Anti-Infective Drugs Market
    • 23.7.4. South Africa Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)

24. Global Anti-infective Drugs Market Competitive Landscape

  • 24.1. Company Profiles
    • 24.1.1. Gilead Sciences
      • 24.1.1.1. Company Overview
      • 24.1.1.2. Products And Services
      • 24.1.1.3. Product Pipeline
      • 24.1.1.4. Business Strategy
      • 24.1.1.5. Financial Overview
    • 24.1.2. GlaxoSmithKline
      • 24.1.2.1. Company Overview
      • 24.1.2.2. Products And Services
      • 24.1.2.3. Product Pipeline
      • 24.1.2.4. Business Strategy
      • 24.1.2.5. Financial Overview
    • 24.1.3. Merck & Co
      • 24.1.3.1. Company Overview
      • 24.1.3.2. Products And Services
      • 24.1.3.3. Product Pipeline
      • 24.1.3.4. Business Strategy
      • 24.1.3.5. Financial Overview
    • 24.1.4. Teva Pharmaceutical Industries Ltd.
      • 24.1.4.1. Company Overview
      • 24.1.4.2. Products And Services
      • 24.1.4.3. Business Strategy
      • 24.1.4.4. Financial Overview
    • 24.1.5. Johnson & Johnson
      • 24.1.5.1. Company Overview
      • 24.1.5.2. Products And Services
      • 24.1.5.3. Product Pipeline
      • 24.1.5.4. Business Strategy
      • 24.1.5.5. Financial Overview

25. Anti-Infective Drugs Market, Key Mergers And Acquisitions

  • 25.1. Cumberaland Pharmaceuticals Acquired Anti- Infective Injection Business Of Theravance Biopharma
  • 25.2. Boston Pharmaceuticals Acquired Novartis' Three Novel Anti-Infective Drugs
  • 25.3. Boston Pharmaceuticals Acquired Five Development Programs From GlaxoSmithKline
  • 25.4. Redx Pharma Signned An Option Deal For Anti-Infective Program With Deinove
  • 25.5. Melinta Therapeutics Acquired The Medicines Company's Infectious Disease Portfolio
  • 25.6. Melinta Therapeutics Merged With Cempra
  • 25.7. Pfizer Acquired Small Molecule Anti-Infective Business From AstraZeneca
  • 25.8. Citius Pharmaceuticals Acquired Leonard-Meron Biosciences
  • 25.9. Johnson & Johnson Acquired Novira Therapeutics, Inc.
  • 25.10. Johnson & Johnson Acquired Alios

26. Market Background: Pharmaceutical Drugs Market

  • 26.1. Pharmaceutical Drugs Market Characteristics
  • 26.2. Market Segmentation By Product Type
    • 26.2.1. Musculoskeletal Drugs
    • 26.2.2. Cardiovascular Drugs
    • 26.2.3. Oncology Drugs
    • 26.2.4. Anti-Infective Drugs
    • 26.2.5. Metabolic Disorders Drugs
    • 26.2.6. Central Nervous System Drugs
    • 26.2.7. Genito-Urinary Drugs
    • 26.2.8. Respiratory Diseases Drugs
    • 26.2.9. Gastrointestinal Drugs
    • 26.2.10. Hematology Drugs
    • 26.2.11. Dermatology Drugs
    • 26.2.12. Ophthalmology Drugs
    • 26.2.13. Pharmaceutical Drugs Market Segmentation
  • 26.3. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
  • 26.4. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 26.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region

27. Global Anti-Infective Drugs Market Opportunities And Strategies

  • 27.1. Global Anti-Infective Drugs Market In 2022 - Countries Offering Most New Opportunities
  • 27.2. Global Anti-Infective Drugs Market In 2022 - Segments Offering Most New Opportunities
  • 27.3. Global Antibiotics Market In 2022 - Sub-Segments Offering Most New Opportunities
    • 27.3.1. Global Antifungals Market In 2022 - Sub-Segments Offering Most New Opportunities
    • 27.3.2. Global Antivirals Market In 2022 - Sub-Segments Offering Most New Opportunities
  • 27.4. Global Anti-Infective Drugs Market In 2022 - Growth Strategies
    • 27.4.1. Market Trend Based Strategies
    • 27.4.2. Competitor Strategies

28. Anti-Infective Drugs Market, Conclusions And Recommendations

  • 28.1. Conclusions
  • 28.2. Recommendations
    • 28.2.1. Product
    • 28.2.2. Price
    • 28.2.3. Place
    • 28.2.4. Promotion
    • 28.2.5. People

29. Appendix

  • 29.1. Market Data Sources
  • 29.2. Research Methodology
  • 29.3. Currencies
  • 29.4. Research Inquiries
  • 29.5. The Business Research Company
  • 29.6. Copyright and Disclaimer
Back to Top